Anticorps Monoclonal anti-CD314/NKG2D
CD314/NKG2D Monoclonal Antibody for FC
Hôte / Isotype
Rat / IgG1, kappa
Réactivité testée
souris
Applications
FC
Conjugaison
Non conjugué
CloneNo.
CX5
N° de cat : 65100-1-Ig
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | C57 mouse splenic NK cells, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
65100-1-Ig cible CD314/NKG2D dans les applications de FC et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Rat / IgG1, kappa |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | Purified Mouse NKG2D protein |
| Nom complet | killer cell lectin-like receptor subfamily K, member 1 |
| Numéro d’acquisition GenBank | BC057147 |
| Symbole du gène | CD314 |
| Identification du gène (NCBI) | 27007 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2-8°C. Stable for one year after shipment. |
Informations générales
CD314, also known as NKG2D or Killer cell lectin-like receptor subfamily K member 1 (KLRK1), is a type II lectin-like transmembrane stimulatory receptor (PMID: 8436421). In mice, CD314 is expressed on NK cells, activated CD8(+) T cells and macrophages, and subsets of TCR gamma delta (+) and NK1.1 (+) T cells (PMID: 12150888). Various subfamilies of MHC class I-related glycoproteins have been identified as the ligands for mouse CD314, including RAET1A, RAET1B, RAET1C, RAET1D, RAET1E, H60 and MULT1 (PMID: 31720075).
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for CD314/NKG2D antibody 65100-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
